Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Donovan

Showing results (511-520 of 694) with videos related to

Pageof 70
Sort By:
Journal of Clinical Epidemiology|January 18, 2011
A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performanceJ Athene Lane, Julia Wade, Liz Down, et al.
BMJ Open|May 1, 2016
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Joanna C Thorn, Emma L Turner, Luke Hounsome, et al.
British Journal of Cancer|May 29, 2003
Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged menD Gunnell, S E Oliver, T J Peters, et al.
Perioperative Medicine (London, England)|June 22, 2022
Evaluating a pre-surgical health optimisation programme: a feasibility studyJoanna McLaughlin, Lauren J Scott, Lucie Owens, et al.
BMC Cancer|October 8, 2020
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trialS Sanghera, S Mohiuddin, J Coast, et al.
BMJ Global Health|May 19, 2021
What empirical research has been undertaken on the ethics of clinical research in India? A systematic scoping review and narrative synthesisSangeetha Paramasivan, Philippa Davies, Alison Richards, et al.
Lancet (London, England)|September 30, 1998
Randomised trial of effectiveness of second eye cataract surgeryD A Laidlaw, R A Harrad, C D Hopper, et al.
Plos One|October 3, 2015
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on BiopsyRebecca Gilbert, Richard M Martin, David M Evans, et al.
The American Journal of Surgical Pathology|January 31, 2015
Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosisAnja C Roden, Eunhee S Yi, Sarah M Jenkins, et al.
Trials|December 19, 2024
The role of healthcare professionals' communication in trial participation decisions: a qualitative investigation of recruitment consultations and patient interviews across three RCTsNicola Farrar, Daisy Elliott, Marcus Jepson, et al.
Pageof 70

Showing results (511-520 of 694) with videos related to

Sort By:
Pageof 70
Journal of Clinical Epidemiology|January 18, 2011
A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performanceJ Athene Lane, Julia Wade, Liz Down, et al.
BMJ Open|May 1, 2016
Validating the use of Hospital Episode Statistics data and comparison of costing methodologies for economic evaluation: an end-of-life case study from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)Joanna C Thorn, Emma L Turner, Luke Hounsome, et al.
British Journal of Cancer|May 29, 2003
Are diet-prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged menD Gunnell, S E Oliver, T J Peters, et al.
Perioperative Medicine (London, England)|June 22, 2022
Evaluating a pre-surgical health optimisation programme: a feasibility studyJoanna McLaughlin, Lauren J Scott, Lucie Owens, et al.
BMC Cancer|October 8, 2020
Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trialS Sanghera, S Mohiuddin, J Coast, et al.
BMJ Global Health|May 19, 2021
What empirical research has been undertaken on the ethics of clinical research in India? A systematic scoping review and narrative synthesisSangeetha Paramasivan, Philippa Davies, Alison Richards, et al.
Lancet (London, England)|September 30, 1998
Randomised trial of effectiveness of second eye cataract surgeryD A Laidlaw, R A Harrad, C D Hopper, et al.
Plos One|October 3, 2015
Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on BiopsyRebecca Gilbert, Richard M Martin, David M Evans, et al.
The American Journal of Surgical Pathology|January 31, 2015
Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosisAnja C Roden, Eunhee S Yi, Sarah M Jenkins, et al.
Trials|December 19, 2024
The role of healthcare professionals' communication in trial participation decisions: a qualitative investigation of recruitment consultations and patient interviews across three RCTsNicola Farrar, Daisy Elliott, Marcus Jepson, et al.
Pageof 70